28 March NEPO Launches Statewide Education Campaign on the Importance of Diversity in Clinical Trials March 28, 2017By CMA Foundation Clinical Trials, NEPO Clinical Trials, NEPO 0 Sacramento, CA (March 28, 2017) – The California Medical Association (CMA) Foundation, through its cornerstone program, the Network of Ethnic Physician Organizations (NEPO), today announced the launch of its “Encouraging Diversity in Clinical Trials” campaign to increase clinical trial participation among California’s multi-ethic patient populations. The campaign is part of the CMA Foundation’s ongoing commitment to raising awareness about critical health disparities and their impact on California’s underserved communities. Clinical trials are research studies designed to evaluate the effects of medical interventions and medicines on patients; to help doctors understand, prevent and treat disease; and to provide patients with opportunities to receive cutting-edge care. Unfortunately, ethnically diverse patients, who have a higher prevalence of some diseases such as sickle cell anemia, heart disease, diabetes, cancer, and high blood pressure, often miss out on the opportunity to participate because they lack access to referrals or feel uncertain about what participation entails. “An unrepresentative ethnic population in clinical trials can hinder progress in the development of safe, efficient, and cost-effective therapies for diseases most prevalent among these patient populations. Some studies show less than five percent participation among minorities and especially among African Americans,” says NEPO Chair Margaret Juarez, M.D. “This is significant, in that, when scientists create treatments, the ethnic make-up is a factor in how medications respond to the body based on dosage, drug, or another factor altogether.” The two-pronged campaign launch entails the distribution of over 350 posters to 25 ethnic physician organizations and medical specialty societies across the state, as well as the launch of a 30-second public service announcement in key markets across the state. “Innovations in treatment are bringing about a revolution in patient care and no individual or groups of Californians should be left behind,” added Juarez. “Participation in clinical trials by diverse communities will help improve health outcomes for patients of color and their families.” Patients interested in participating in clinical trials should discuss the topic with their health care provider and visit www.clinicaltrials.gov. For more information about the “Encouraging Diversity in Clinical Trials” campaign or the CMA Foundation, visit www.thecmafoundation.org. Follow the campaign on Facebook and Twitter. Comments are closed.